Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?

Clinical Endocrinology

Volumn 80, Issue 5, 2014, Pages 685-690

  Alexandraki, Krystallenia I ^a   Nikolaou, Argiro ^a   Thomas, Dimitrios ^a   Syriou, Vassiliki ^a   Korkolopoulou, Penelope ^a   Sougioultzis, Stavros ^a   Kaltsas, Gregory ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; GASTRIN; PARIETAL CELL ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE GASTRITIS; CANCER RISK; CELL HYPERPLASIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROCHROMAFFIN LIKE CELL HYPERPLASIA; FEMALE; GASTRIC NEUROENDOCRINE TUMOR TYPE 1; GASTRIN BLOOD LEVEL; GASTRITIS; GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR; GASTROINTESTINAL ENDOSCOPY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; OBSERVATIONAL STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STOMACH BIOPSY; STOMACH MUCOSA; UPPER GASTROINTESTINAL TRACT ENDOSCOPY; AGED; AUTOIMMUNE DISEASES; BLOOD; COMPLICATION; CYTOLOGY; ENDOSCOPY; ENTEROCHROMAFFIN LIKE CELL; GENETICS; HELICOBACTER INFECTION; MIDDLE AGED; NEUROENDOCRINE TUMORS; PHENOTYPE; PREVALENCE; RISK; STOMACH TUMOR; THYROID DISEASES;

AGED; AUTOIMMUNE DISEASES; CHROMOGRANIN A; ENDOSCOPY; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRINS; GASTRITIS; HASHIMOTO DISEASE; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; RISK; STOMACH NEOPLASMS; THYROID DISEASES;

EID: 84898543025     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12346     Document Type: Article

References (20)

1. Checchi, S., Montanaro, A., Ciuoli, C., et al,. (2010) Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis. Thyroid, 20, 1385-1389.
2. Centanni, M., Marignani, M., Gargano, L., et al,. (1999) Atrophic body gastritis in patients with autoimmune thyroid disease. Archives of Internal Medicine, 159, 1726-1730.
3. Lahner, E., Norman, G., Severi, C., et al,. (2009) Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. The American Journal of Gastroenterology, 104, 2071-2079.
4. Marignani, M., Delle Fave, G., Mecarocci, S., et al,. (1999) High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anaemia. The American Journal of Gastroenterology, 94, 766-772.
5. Bektaş, M., Saraç, N., Çetinkaya, H., et al,. (2012) Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells. Annals of Gastroenterology, 25, 123-127.
6. Havu, N., Maaroos, H.I., &, Sipponen, P., (1991) Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease. Scandinavian Journal of Gastroenterology Supplement, 186, 90-94.
7. Tsolakis, A.V., (2008) Characterization of Endocrine Cells and Tumours in the Stomach. Acta Universitatis Upsaliensis, Uppsala, 11-62.
8. Annibale, B., Di Giulio, E., Caruana, P., et al,. (2002) The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Alimentary Pharmacology and Therapeutics, 16, 1723-1731.
9. Delle Fave, G., Kwekkeboom, D.J., Van Cutsem, E., et al,. (2012) ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology, 95, 74-87.
10. Thomas, D., Tsolakis, A.V., Grozinsky-Glasber, S., et al,. (2013) Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors. Data from a multicenter study. European Journal of Endocrinology, 168, 185-193.
11. Niederle, M.B., Hackl, M., Kaserer, K., et al,. (2010) Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocrine Related Cancer, 17, 909-918.
12. Dixon, M.F., Genta, R.M., Yardley, J.H., et al,. (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the histopathology of gastritis, Houston 1994. American Journal of Pathology, 20, 1161-1181.
13. Bordi, C., Yu, J.Y., Baggi, M.T., et al,. (1991) Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer, 67, 663-672.
14. Solcia, E., Fiocca, R., Villani, L., et al,. (1995) Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. The American Journal of Surgical Pathology, 19 (Suppl 1), S1-S7.
15. Elisei, R., Mariotti, S., Swillens, S., et al,. (1990) Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell. Autoimmunity, 8, 65-70.
16. Segni, M., Borrelli, O., Pucarelli, I., et al,. (2004) Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid diseases. Journal of Clinical Endocrinology and Metabolism, 89, 4944-4948.
17. Peracchi, M., Gebbia, C., Basilisco, G., et al,. (2005) Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. European Journal of Endocrinology, 152, 443-448.
18. Armbrecht, U., Stockbrügger, R.W., Rode, J., et al,. (1990) Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut, 31, 1105-1109.
19. Tozzoli, R., Kodermaz, G., Perosa, A.R., et al,. (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmunity Reviews, 10, 80-83.
20. Checchi, S., Montanaro, A., Pasqui, L., et al,. (2008) L-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. Journal of Clinical Endocrinology and Metabolism, 93, 465-469.